From Weight Loss Drugs to Cancer Vaccines: A Contrarian Bet on Two Biotech Stocks Jan 27, 2026 Life Science
Massive Upside Potential: Two Canadian Growth Stocks for Risk-Tolerant Investors Jan 21, 2026 Life Science, Precious Metals
GSK to Acquire RAPT Therapeutics for $2.2 Billion, Bolstering Food Allergy Pipeline Jan 20, 2026 Life Science
ImmunityBio Soars Over 30% as Bladder Cancer Drug Anktiva Delivers Breakout Growth Jan 15, 2026 Life Science
Eli Lilly and Novo Nordisk: The Battle for Dominance in the 2026 Weight-Loss Drug Market Jan 13, 2026 Life Science
A Trump Tariff Victory? U.S. Trade Gap Nosedives, But Economists See a Mirage Jan 8, 2026 Life Science, Precious Metals
Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio Jan 7, 2026 Life Science
